Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Focus on drug interactions with a common food: grapefruit

June 5, 1997

Shaman issued U.S. patents for type II diabetes compounds

June 4, 1997

U. of California discloses mammalian EPO-BP

June 4, 1997

ACE inhibitors inhibit bone resorption in vitro

June 3, 1997

AGE inhibitor described by Kissei

June 3, 1997

Positive efficacy profile reported for Zonagen's Vasomax

May 30, 1997

Ono reports AGE inhibitors and antioxidants

May 29, 1997

Kyoto describes ACAT/lipid peroxidation inhibitors

May 29, 1997

Merck & Co. acquires majority share of Gentili

May 28, 1997

Nissan Chem. reveals new antidiabetic agents

May 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...